Belite Bio BLTE
$127.38 −$23.64 (-15.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $127.38 0.00%
Open$129.00
Prev close$151.02
Day range$120.00 – $135.07
Volume1.04M
Market cap$5.17B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$36.91M-60.4% YoY
Net profit-$30.27M-39.6% YoY
Diluted EPS-$0.75-15.4% YoY
Free cash flow-$10.56M-129.3% YoY
Operating cash flow-$10.39M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Annual revenue
Profitability & balance sheet
Return on equity-21.2%
Return on assets-20.7%
Return on invested capital-21.2%
Liabilities / assets2.4%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $36.91M | $34.91M | $32.68M | $84.21M | $28.08M |
| Selling and Admin Expenses | $21.43M | $16.69M | $17.02M | $38.83M | $13.45M |
| -General & Admin Expense | $21.43M | $16.69M | $17.02M | $38.83M | $13.45M |
| Research & Development | $15.48M | $18.21M | $15.66M | $45.38M | $14.62M |
| Operating Profit | -$36.91M | -$34.91M | -$32.68M | -$84.21M | -$28.08M |
| Other Income (Expense) | $6.65M | $6.55M | $5.75M | -$41,000.00 | -$3.89M |
| Other Non-Operating Income (Expenses) | $6.65M | $6.55M | $5.75M | -$41,000.00 | -$3.89M |
| Pretax Profit | -$30.26M | -$28.36M | -$26.94M | -$77.61M | -$25.32M |
| Tax | $13,000.00 | $55,000.00 | – | $0.00 | $0.00 |
| Net Profit | -$30.27M | -$28.41M | -$26.94M | -$77.61M | -$25.32M |
| Profit from Continuing Operations | -$30.27M | -$28.41M | -$26.94M | -$77.61M | -$25.32M |
| Net Income to Parent Company | -$30.27M | -$28.41M | -$26.94M | -$77.61M | -$25.32M |
| Net Income to Common Stockholders | -$30.27M | -$28.41M | -$26.94M | -$77.61M | -$25.32M |
| Basic EPS | -$0.75 | -$0.70 | -$0.68 | -$2.31 | -$0.70 |
| Diluted EPS | -$0.75 | -$0.70 | -$0.68 | -$2.31 | -$0.70 |
| Net Non-Operating Interest Income (Expense) | – | – | – | $6.64M | $3.17M |
| Non-Operating Interest Income | – | – | – | $6.64M | $3.17M |
| Non-Operating Interest Expense | – | – | – | $2,000.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $789.74M | $791.58M | $811.27M | $780.56M | $780.56M |
| Total Current Assets | $498.35M | $501.60M | $521.86M | $494.27M | $494.27M |
| Total Non-Current Assets | $291.39M | $289.98M | $289.41M | $286.28M | $286.28M |
| Other Non-Current Assets | $291.39M | $289.98M | $289.41M | – | – |
| Total Liabilities | $18.68M | $14.95M | $15.48M | $10.07M | $10.07M |
| Total Equity | $771.06M | $776.64M | $795.79M | $770.49M | $770.49M |
| Stockholders' Equity | $771.06M | $776.64M | $795.79M | $770.49M | $770.49M |
| Cash and Cash Equivalents & Short-Term Investments | – | – | – | $492.42M | $492.42M |
| -Cash and Cash Equivalents | – | – | – | $352.93M | $352.93M |
| -Short Term Investments | – | – | – | $139.49M | $139.49M |
| Receivables | – | – | – | $718,000.00 | $718,000.00 |
| -Accrued Interest Receivable | – | – | – | $634,000.00 | $634,000.00 |
| -Taxes Receivable | – | – | – | $18,000.00 | $18,000.00 |
| -Other Receivables | – | – | – | $66,000.00 | $66,000.00 |
| Prepaid Assets | – | – | – | $1.13M | $1.13M |
| Other Current Assets | – | – | – | $5,000.00 | $5,000.00 |
| Net PPE | – | – | – | $777,000.00 | $777,000.00 |
| -Gross PPE | – | – | – | $1.28M | $1.28M |
| -Accumulated Depreciation | – | – | – | -$507,000.00 | -$507,000.00 |
| Investments and Advances | – | – | – | $280.17M | $280.17M |
| -Held to Maturity Securities | – | – | – | $280.17M | $280.17M |
| Non-Current Prepaid Assets | – | – | – | $425,000.00 | $425,000.00 |
| Goodwill and Other Intangible Assets | – | – | – | $4.92M | $4.92M |
| -Other Intangible Assets | – | – | – | $4.92M | $4.92M |
| Total Current Liabilities | – | – | – | $9.88M | $9.88M |
| Payables | – | – | – | $5,000.00 | $5,000.00 |
| -Due to Related Parties Current | – | – | – | $5,000.00 | $5,000.00 |
| Current Accrued Expenses | – | – | – | $7.43M | $7.43M |
| Short-Term Debt and Capital Lease Obligation | – | – | – | $241,000.00 | $241,000.00 |
| -Current Capital Lease Obligation | – | – | – | $241,000.00 | $241,000.00 |
| Other Current Liabilities | – | – | – | $599,000.00 | $599,000.00 |
| Total Non-Current Liabilities | – | – | – | $188,000.00 | $188,000.00 |
| Long Term Debt and Capital Lease Obligation | – | – | – | $188,000.00 | $188,000.00 |
| -Long Term Capital Lease Obligation | – | – | – | $188,000.00 | $188,000.00 |
| Capital Stock | – | – | – | $4,000.00 | $4,000.00 |
| -Common Stock | – | – | – | $4,000.00 | $4,000.00 |
| Additional Paid-In Capital | – | – | – | $956.28M | $956.28M |
| Retained Earnings | – | – | – | -$185.26M | -$185.26M |
| Gains/Losses Not Affecting Retained Earnings | – | – | – | -$536,000.00 | -$536,000.00 |
Cash flow
| Line item | 2025 ANNUAL | 2025 Q4 | 2024 ANNUAL | 2024 Q4 | 2023 ANNUAL |
|---|---|---|---|---|---|
| Operating Cash Flow | -$36.99M | -$10.39M | -$29.23M | -$4.60M | -$29.84M |
| Net cash flow from continuing operations | -$36.99M | -$10.39M | -$29.23M | -$4.60M | -$29.84M |
| Net Income from Continuing Operations | -$77.61M | -$25.32M | -$36.14M | -$10.10M | -$31.63M |
| Depreciation & Depletion & Amortization | $464,000.00 | $117,000.00 | $449,000.00 | $118,000.00 | $399,000.00 |
| Other Non-Cash Items | -$1.31M | $1.85M | -$3.61M | -$1.20M | – |
| Change in Working Capital | $2.55M | $1.26M | $1.13M | $2.42M | -$2.43M |
| -Change in Receivables | -$66,000.00 | -$60,000.00 | $74,000.00 | $0.00 | -$72,000.00 |
| -Change in Prepaid Assets | -$918,000.00 | -$441,000.00 | -$1.11M | -$401,000.00 | -$3.53M |
| -Change in Payables and Accrued Expense | $3.84M | $1.84M | $2.48M | $2.90M | $1.42M |
| -Change in Other Current Liabilities | -$301,000.00 | -$74,000.00 | -$305,000.00 | -$77,000.00 | -$244,000.00 |
| Net cash flow from investing | -$305.11M | -$303.73M | -$110.57M | -$26.01M | -$63,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$305.11M | -$303.73M | -$110.57M | -$26.01M | -$63,000.00 |
| Net PPE Purchase and Sale | -$178,000.00 | -$178,000.00 | -$116,000.00 | $0.00 | -$63,000.00 |
| Net Intangibles Purchase and Sale | $0.00 | $0.00 | -$35,000.00 | -$6,000.00 | $0.00 |
| Net Investment Purchase and Sale | -$304.93M | -$303.56M | -$110.42M | -$26.01M | $0.00 |
| Financing Cash Flow | $663.23M | $510.12M | $83.60M | $39.78M | $75.96M |
| Net Cash Flow from Continuing Financing Activities | $663.23M | $510.12M | $83.60M | $39.78M | $75.96M |
| Net Common Stock Issuance | $182.02M | $28.97M | $42.24M | $10.48M | $55.19M |
| Proceeds from Stock Option Exercised | $110.84M | $104.02M | $41.73M | $29.44M | $22.00M |
| Net Other Financing Charges | $370.37M | $377.13M | -$368,000.00 | -$149,000.00 | -$1.23M |
| Ending Cash Balance | $352.93M | $352.93M | $31.68M | $31.68M | $88.16M |
| Net Change in Cash | $321.14M | $196.00M | -$56.21M | $9.16M | $46.06M |
| Beginning Cash Balance | $31.68M | $157.03M | $88.16M | $22.79M | $42.09M |
| Effect of Exchange Rate Changes | $117,000.00 | -$101,000.00 | -$269,000.00 | -$277,000.00 | $9,000.00 |
| Free Cash Flow | -$37.17M | -$10.56M | -$29.39M | -$4.61M | -$29.90M |
No comments yet — be the first to weigh in on BLTE.
Sign in to join the discussion.